Diamond BiofundTPE:6901 +9.86%16 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates TPE:6901 with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 668 Asset Management companies, Diamond Biofund ranks worse than 149700.45% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Diamond Biofund's EBITDA for the
three
months ended in Dec. 2025 was NT$-7.25 Mil. Diamond Biofund's Revenue for the
three
months ended in Dec. 2025 was NT$0.00 Mil. Therefore, Diamond Biofund's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Diamond Biofund EBITDA Margin % Related Terms
Diamond Biofund EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Diamond Biofund's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6901 vs BLK, BX, KKR: EBITDA Margin % Comparison
For the Asset Management subindustry, Diamond Biofund's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diamond Biofund EBITDA Margin % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Diamond Biofund's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Diamond Biofund's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diamond Biofund (TPE:6901) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Diamond Biofund and its competitors. According to the industry distribution chart, Diamond Biofund ranks #999999 out of 668 companies in the Asset Management industry.
Is Diamond Biofund's EBITDA Margin % too high?
Diamond Biofund's current EBITDA Margin % is 0.00%. Based on the distribution chart, Diamond Biofund ranks #999999 out of 668 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, Diamond Biofund has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Diamond Biofund's EBITDA Margin % compare to BLK and BX?
According to the Asset Management industry distribution chart, Diamond Biofund ranks #999999 out of 668 companies for EBITDA Margin %. This places Diamond Biofund in the lower half of its industry. The industry median EBITDA Margin % is 30.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Asset Management company?
The median EBITDA Margin % among Asset Management companies is 30.19, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Diamond Biofund and its competitors. For the Asset Management industry, the median EBITDA Margin % is 30.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diamond Biofund's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biofund stock overvalued right now?
Diamond Biofund (TPE:6901) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Diamond Biofund's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Diamond Biofund (TPE:6901), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
16GF Score
Get the complete analysis for TPE:6901
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6901 has been successfully added to your 
